MEDIAN Technologies strengthens its medical expertise department by appointing Dr. Nathalie Faye as Medical Director Europe
MEDIAN Technologies (ALMDT), a leading medical imaging solutions and service provider for image interpretation and management in oncology, today announces the appointment of Dr. Nathalie Faye, M.D as the company’s Medical Director, Europe.
Dr. Faye joins MEDIAN Technologies to strengthen the medical expertise department, and will work under the responsibility of Dr. Souhil Zaim, MEDIAN’s chief medical officer. As an imaging expert, she will be involved in all Europe based operations led by MEDIAN Technologies, focusing on clinical trial operations. Dr. Faye will be also involved in MEDIAN’s R&D activities where her imaging expertise will be an asset in the development of MEDIAN proprietary Lesion Management Solutions (LMS) new functionalities and extension to other therapeutic areas.
Dr. Faye, MD, PhD is a board certified radiologist with over 10 years of experience in imaging for clinical trials with the biopharmaceutical industry. Prior to joining MEDIAN Technologies, Dr. Faye was assistant professor of radiology (2011-2013) at the university hospital of Lille, France. She had worked previously as a visiting fellow and expert reader at Synarc, San Francisco, California, USA (2005-2012) and MEDIAN (since 2014).
Dr. Faye received her medical degree and completed her radiology residency and fellowship at the University of Paris, School of Medicine, France. She was assistant professor at the department of radiology at the Curie Institute, Paris (France). She also obtained a master and a doctorate degree in medical imaging (focused on functional and cellular imaging) in Paris.